about
Peroxisome proliferator-activated receptors as stimulants of angiogenesis in cardiovascular disease and diabetes.Activation of peroxisome proliferator-activated receptor-{delta} enhances regenerative capacity of human endothelial progenitor cells by stimulating biosynthesis of tetrahydrobiopterinRosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS.Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.Activation of PPAR-δ induces microRNA-100 and decreases the uptake of very low-density lipoprotein in endothelial cells.Reactive oxygen species signaling facilitates FOXO-3a/FBXO-dependent vascular BK channel β1 subunit degradation in diabetic mice.Peroxisome proliferator-activated receptor-β/δ regulates angiogenic cell behaviors and oxygen-induced retinopathy.The role of pioglitazone in modifying the atherogenic lipoprotein profile.Prognostic and therapeutic potential of nuclear receptors in head and neck squamous cell carcinomas.Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-δ gene.Peroxisome proliferator-activated receptor α ligands and modulators from dietary compounds: Types, screening methods and functions.Peroxisome proliferator-activated receptor (PPAR) α and δ activators induce ICAM-1 expression in quiescent non stimulated endothelial cells.Cross-enhancement of ANGPTL4 transcription by HIF1 alpha and PPAR beta/delta is the result of the conformational proximity of two response elementsPeroxisome proliferator-activated receptor {delta} activators induce IL-8 expression in nonstimulated endothelial cells in a transcriptional and posttranscriptional manner.The PPARδ ligand L-165041 inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ.
P2860
Q34620720-BF178140-44F0-4DDA-834F-4E0322EC34ABQ35126265-5CB4051E-74DF-4789-8D8C-47AB1CCF919FQ35608658-261B6645-AA54-4D60-BD50-CBC08E384AD0Q35636191-3D0BE659-03F4-4140-9777-4152831C25F2Q35911725-E9A55F1B-1834-4690-BE76-826C6363C3FBQ36047479-24F9AE81-1067-4B5C-B7F0-5047301B1471Q36943828-32BCDCE2-4660-4D9D-BC40-F91D5E5EE367Q37516536-0968E2CB-72D7-4D1B-891B-26F1D80DAD3EQ37606299-FB4D9713-527C-4AE0-884B-8B328E05F126Q37656075-06E17162-16AA-4B8A-930E-670F23545377Q39013200-201F25C1-EB05-4988-AE55-6E2F409A9686Q39468345-6A8B83B8-F3A1-4E2A-BC28-813B21B0F6CAQ40587087-833D0582-C64B-4D4D-8E5B-86855759C187Q42400879-7E84162E-F8BE-4100-AB8B-CD4E66BBEE7EQ53193081-9ACC9277-5BBF-44B7-A15D-8DAF8BB2530D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PPAR-delta in Vascular Pathophysiology.
@en
PPAR-delta in Vascular Pathophysiology.
@nl
type
label
PPAR-delta in Vascular Pathophysiology.
@en
PPAR-delta in Vascular Pathophysiology.
@nl
prefLabel
PPAR-delta in Vascular Pathophysiology.
@en
PPAR-delta in Vascular Pathophysiology.
@nl
P2860
P356
P1433
P1476
PPAR-delta in Vascular Pathophysiology.
@en
P2093
Nanping Wang
P2860
P304
P356
10.1155/2008/164163
P577
2008-01-01T00:00:00Z